Scott A. Smith - Jun 14, 2023 Form 4 Insider Report for BioAtla, Inc. (BCAB)

Role
Director
Signature
/s/ Christian Vasquez, as Attorney-in-Fact for Scott A. Smith
Stock symbol
BCAB
Transactions as of
Jun 14, 2023
Transactions value $
$0
Form type
4
Date filed
6/15/2023, 06:43 PM
Previous filing
Jun 1, 2023
Next filing
Jul 3, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCAB Stock Option (Right to Buy) Award $0 +50K $0.00 50K Jun 14, 2023 Common Stock 50K $3.55 Direct F1
transaction BCAB Stock Option (Right to Buy) Award $0 +5.9K $0.00 5.9K Jun 14, 2023 Common Stock 5.9K $3.55 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the total number of shares subject to the option shall vest and become exercisable on the earlier of (a) June 14, 2024 or (b) the day before the next annual meeting of stockholders, subject to the reporting person continuing to provide services through the vesting date.
F2 Fully vested and exercisable.